X4 Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
XFOR X4 Pharmaceuticals Inc
EDUC Educational Development Corp
FLR Fluor Corp
DMPI DelMar Pharmaceuticals Inc
SPLK Splunk Inc
LB L Brands Inc
TEAM Atlassian Corporation PLC
GRAS Greenfield Farms Food Inc
CMS CMS Energy Corp
BAC Bank of America Corp
Go

Company profile

X4 Pharmaceuticals, Inc., formerly Arsanis, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003.

Price
Delayed
$17.69
Day's Change
0.66 (3.88%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.61
Day's Low
16.80
Volume
(Light)

Today's volume of 10,589 shares is on pace to be much lighter than XFOR's 10-day average volume of 55,693 shares.

10,589
  • Prev Close
    17.03
  • Today's Open
    16.80
  • Day's Range
    16.80-18.61
  • Avg Vol (10-day)
    55.7K
  • Last (time)
    1:24p ET 05/23/19
  • Last (size)
    100
  • 52-Wk Range
    6.90 - 114.00
    LowHigh
  • (06/04/18 - 11/14/18)
    156.38%
  • 224.9%
  • Market Cap
    219.7M
  • Shares Outstanding
    12.4M
  • -20.25
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 47.68
  • (% of float 04/30/19)
    1.62

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.